Neutralization of interleukin-17A delays progression of silica-induced lung inflammation and fibrosis in C57BL/6 mice

Toxicology and Applied Pharmacology

Volumn 275, Issue 1, 2014, Pages 62-72

  Chen, Ying ^a   Li, Cuiying ^a   Weng, Dong ^a,b   Song, Laiyu ^a   Tang, Wen ^a   Dai, Wujing ^a   Yu, Ye ^a   Liu, Fangwei ^a   Zhao, Ming ^a   Lu, Chunwei ^a   Chen, Jie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

ANA; BALF; HLN; IL 17A; Interleukin 17A; Lung fibrosis; Lung Inflammation; Silica; Th17; Tregs

Indexed keywords

IL-17A; LUNG FIBROSIS; LUNG INFLAMMATION; SILICA; TH17;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, NEUTRALIZING; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-6; LUNG; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; PNEUMONIA; PULMONARY FIBROSIS; RANDOM ALLOCATION; SILICOSIS; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 84894035265     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.11.012     Document Type: Article

References (54)

1. Alcorn J.F., Crowe C.R., Kolls J.K. Th17 cells in asthma and COPD. Annu. Rev. Physiol. 2010, 72:495-516.
2. Barbarin V., Arras M., Misson P., Delos M., McGarry B., Phan S.H., Lison D., Huaux F. Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice. Am. J. Respir. Cell Mol. Biol. 2004, 31(1):78-85.
3. Bettelli E., Carrier Y., Ago W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
4. Brown J.M., Archer A.J., Pfau J.C., Holian A. Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice. Clin. Exp. Immunol. 2003, 131(3):415-421.
5. Brown J.M., Swindle E.J., Kushnir-Sukhov N.M., Holian A., Metcalfe D.D. Silica-directed mast cell activation is enhanced by scavenger receptors. Am. J. Respir. Cell Mol. Biol. 2007, 36:43-52.
6. Chaudhry A., Rudensky A.Y. Control of inflammation by integration of environmental cues by regulatory T cells. J. Clin. Invest. 2013, 123(3):939-944.
7. Chen Y., Chen J., Dong J., Liu W. Antifibrotic effect of interferon gamma in silicosis model of rat. Toxicol. Lett. 2005, 155(3):353-360.
8. Chen Z., O'Shea J.J. Th17 cells: a new fate for differentiating helper T cells. Immunol. Res. 2008, 41(2):87-102.
9. Coccia M., Harrison O.J., Schiering C., Asquith M.J., Becher B., Powrie F., Maloy K.J. IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J. Exp. Med. 2012, 209(9):1595-1609.
10. Dardalhon V., Korn T., Kuchroo V.K., Anderson A.C. Role of Th1 and Th17 cells in organ-specific autoimmunity. J. Autoimmun. 2008, 31:252-256.
11. Davis G.S., Pfeiffer L.M., Hemenway D.R. Expansion of interferon-gamma-producing lung lymphocytes in mouse silicosis. Am. J. Respir. Cell Mol. Biol. 1999, 20:813-824.
12. Davis G.S., Pfeiffer L.M., Hemenway D.R. Interferon-gamma production by specific lung lymphocyte phenotypes in silicosis in mice. Am. J. Respir. Cell Mol. Biol. 2000, 22:491-501.
13. de St Groth B.F. Regulatory T-cell abnormalities and the global epidemic of immuno-inflammatory disease. Immunol. Cell Biol. 2012, 90(3):256-259.
14. Fujimoto M., Nakano M., Terabe F., Kawahata H., Ohkawara T., Han Y., Ripley B., Serada S., Nishikawa T., Kimura A., Nomura S., Kishimoto T., Naka T. The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cells. J. Immunol. 2011, 186(1):32-40.
15. Fujimoto M., Serada S., Mihara M., Uchiyama Y., Yoshida H., Koike N., Ohsugi Y., Nishikawa T., Ripley B., Kimura A., Kishimoto T., Naka T. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses. Arthritis Rheum. 2008, 58(12):3710-3719.
16. Fujimura N. Pathology and pathophysiology of pneumoconiosis. Curr. Opin. Pulm. Med. 2000, 6(2):140-144.
17. Gasse P., Riteau N., Vacher R., Michel M.L., Fautrel A., di Padova F., Fick L., Charron S., Lagente V., Eberl G., Le Bert M., Quesnia V.F., Huaux F., Leite-de-Moraes M., Ryffel B., Couillin I. IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. PloS One 2011, 6(8):e23185.
18. Guo J., Gu N., Chen J., Shi T., Zhou Y., Rong Y., Zhou T., Yang W., Cui X., Chen W. Neutralization of interleukin-1 beta attenuates silica-induced lung inflammation and fibrosis in C57BL/6 mice. Arch. Toxicol. 2013, 87(11):1963-1973.
19. Hayashi H., Miura Y., Maeda M., Murakami S., Kumagai N., Nishimura Y., Kusaka M., Urakami K., Fujimoto W., Otsuki T. Reductive alteration of the regulatory function of the CD4(+)CD25(+) T cell fraction in silicosis patients. Int. J. Immunopathol. Pharmacol. 2010, 23(4):1099-1109.
20. Henness S., Johnson C.K., Ge Q., Armour C.L., Hughes J.M., Ammit A.J. IL-17A augments TNF-alpha-induced IL-6 expression in airway smooth muscle by enhancing mRNA stability. J. Allergy Clin. Immunol. 2004, 114(4):958-964.
21. Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., Fitzgerald K.A., Latz E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 2008, 9:847-856.
22. Huaux F. New developments in the understanding of immunology in silicosis. Curr. Opin. Allergy Clin. Immunol. 2007, 7:168-173.
23. Huaux F., Arras M., Tomasi D., Barbarin V., Delos M., Coutelier J.P., Vink A., Phan S.H., Renauld J.C., Lison D. A profibrotic function of IL-12p40 in experimental pulmonary fibrosis. J. Immunol. 2002, 169:2653-2661.
24. Huh J.R., Littman D.R. Small molecule inhibitors of RORγt: targeting Th17 cells and other applications. Eur. J. Immunol. 2012, 42:2232-2237.
25. Jagirdar J., Begin R., Dufresne A., Goswami S., Lee T.C., Rom W.N. Transforming growth factor-beta (TGF-beta) in silicosis. Am. J. Respir. Crit. Care Med. 1996, 154:1076-1081.
26. Joshi A.D., Fong D.J., Oak S.R., Trujillo G., Flaherty K.R., Martinez F.J., Hogaboam C.M. Interleukin-17-mediated immunopathogenesis in experimental hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 2009, 179(8):705-716.
27. Jovanovic D.V., Di Battista J.A., Martel-Pelletier J., Jolicoeur F.C., He Y., Zhang M., Mineau F., Pelletier J.P. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol. 1998, 160(7):3513-3521.
28. Korn T., Bettelli E., Gao W., Awasthi A., Jager A., Strom T.B., Oukka M., Kuchroo V.K. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007, 448(7152):484-487.
29. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009, 27:485-517.
30. Lee S., Hayashi H., Maeda M., Chen Y., Matsuzaki H., Takei-Kumagai N., Nishimura Y., Fujimoto W., Otsuki T. Environmental factors producing autoimmune dysregulation-chronic activation of T cells caused by silica exposure. Immunobiology 2012, 217(7):743-748.
31. Leung C.C., Yu I.T., Chen W. Silicosis. Lancet 2012, 379(9830):2008-2018.
32. Li X.L., Dou Y.C., Liu Y., Shi C.W., Cao L.L., Zhang X.Q., Zhu J., Duan R.S. Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells. Cell. Immunol. 2011, 271(2):455-461.
33. Liu F., Liu J., Weng D., Chen Y., Song L., He Q., Chen J. CD4+CD25+Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice. PLoS One 2010, 5(11):e15404.
34. Lo Re S., Dumoutier L., Couillin I., Van Vyve C., Yakoub Y., Uwambayinema F., Marien B., van den BrÛle S., Van Snick J., Uyttenhove C., Ryffel B., Renauld J.C., Lison D., Huaux F. IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis. J. Immunol. 2010, 184:6367-6377.
35. Mi S., Li Z., Yang H.Z., Liu H., Wang J.P., Ma Y.G., Wang X.X., Liu H.Z., Sun W., Hu Z.W. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms. J. Immunol. 2011, 187(6):3003-3014.
36. Migliaccio C.T., Buford M.C., Jessop F., Holian A. The IL-4Ralpha pathway in macrophages and its potential role in silica-induced pulmonary fibrosis. J. Leukoc. Biol. 2008, 83:630-639.
37. Nembrini C., Marsland B.J., Kopf M. IL-17-producing T cells in lung immunity and inflammation. J. Allergy Clin. Immunol. 2009, 123:986-994.
38. Otsuki T., Maeda M., Murakami S., Hayashi H., Miura Y., Kusaka M., Nakano T., Fukuoka K., Kishimoto T., Hyodoh F., Ueki A., Nishimura Y. Immunological effects of silica and asbestos. Cell. Mol. Immunol. 2007, 4(4):261-268.
39. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
40. Park M.J., Park H.S., Oh H.J., Lim J.Y., Yoon B.Y., Kim H.Y., Cho M.L., Cho S.G. IL-17-deficient allogeneic bone marrow transplantation prevents the induction of collagen-induced arthritis in DBA/1J mice. Exp. Mol. Med. 2012, 44(11):694-705.
41. Rabolli V., Lo Re S., Uwambayinema F., Yakoub Y., Lison D., Huaux F. Lung fibrosis induced by crystalline silica particles is uncoupled from lung inflammation in NMRI mice. Toxicol. Lett. 2011, 203(2):127-134.
42. Rangachari M., Mauermann N., Marty R.R., Dirnhofer S., Kurrer M.O., Komnenovic V., Penninger J.M., Eriksson U. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J. Exp. Med. 2006, 7:2009-2019.
43. Rimal B., Greenberg A.K., Rom W.N. Basic pathogenetic mechanisms in silicosis: current understanding. Curr. Opin. Pulm. Med. 2005, 11(2):169-173.
44. Sakaguchi S., Wing K., Onishi Y., Prieto-Martin P., Yamaguchi T. Regulatory T cells: how do they suppress immune responses?. Int. Immunol. 2009, 21(10):1105-1111.
45. Simonian P.L., Roark C.L., Wehrmann F., Lanham A.K., Diaz del Valle F. Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis. J. Immunol. 2009, 182:657-665.
46. Song L., Weng D., Liu F., Chen Y., Li C., Dong L., Tang W., Chen J. Tregs promote the differentiation of Th17 cells in silica-induced lung fibrosis in mice. PLoS One 2012, 7(5):e37286.
47. Steenland K., Goldsmith D.F. Silica exposure and autoimmune diseases. Am. J. Ind. Med. 1995, 28:603-608.
48. Strieter R.M., Kunkel S.L. Acute lung injury: the role of cytokines in the elicitation of neutrophils. J. Investig. Med. 1994, 42:640-651.
49. Suzuki N., Ohta K., Horiuchi T., Takizawa H., Ueda T., Kuwabara M., Shiga J., Ito K. T lymphocytes and silica-induced pulmonary inflammation and fibrosis in mice. Thorax 1996, 51:1036-1042.
50. Szapiel S.V., Elson N.A., Fulmer J.D., Hunninghake G.W., Crystal R.G. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am. Rev. Respir. Dis. 1979, 120:893-899.
51. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
52. Vojdani A. Antibodies as predictors of complex autoimmune diseases. Int. J. Immunopathol. Pharmacol. 2008, 21(2):267-278.
53. Wilson M.S., Madala S.K., Ramalingam T.R., Gochuico B.R., Rosas I.O., Cheever A.W., Wynn T.A. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J. Exp. Med. 2010, 207(3):535-552.
54. Wu P., Miura Y., Hyodoh F., Nishimura Y., Hatayama T., Hatada S., Sakaguchi H., Kusaka M., Katsuyama H., Tomita M., Otsuki T. Reduced function of CD4+25+ regulatory T cell fraction in silicosis patients. Int. J. Immunopathol. Pharmacol. 2006, 19:357-368.